AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Suregraft 0.25 Tablet

Prescription Icon
Prescription Required

Marketer

Hospimax Healthcare Pvt Ltd

Salt Composition

Everolimus (0.25mg)

Overview Suregraft 0.25 Tablet

Tacrolimus 0.25mg tablets help prevent organ rejection following transplantation by modulating the immune system's response to the new organ. This medication is also used alongside other treatments for breast, pancreatic, lung, and kidney cancers. Always adhere to your doctor's prescribed dosage and regimen. It can be taken with or without food, but consistency in timing is crucial. Overdosing can lead to severe adverse effects. Common side effects may include infections (respiratory or otherwise), fever, cough, tiredness, diarrhea, and fatigue. Report any persistent or troubling side effects to your physician immediately. Seek immediate medical attention for allergic reactions such as rash, breathing difficulties, swelling, or cough. Consult your doctor before taking this medicine if you experience excessive thirst, frequent urination, shortness of breath, cough, fever, or require any vaccinations. Always inform your doctor about all current medications and underlying health conditions before starting treatment. Pregnant or breastfeeding individuals must discuss this medication with their physician before use. Regular blood tests may be recommended to monitor the drug's effects. This medication may impact fertility in both men and women; discuss family planning with your doctor.

Primary Ingredients of Suregraft 0.25 Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Suregraft 0.25 Tablet

Preventing graft rejection in transplant recipients

Major Benefits of Suregraft 0.25 Tablet:

Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Suregraft 0.25mg tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Suregraft 0.25 Tablet:

  • Infection
  • Fever
  • Cough
  • Fatigue
  • Diarrhea
  • Upper respiratory tract infection

How to use Suregraft 0.25 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Suregraft 0.25mg tablets can be consumed with or without food, though consistent timing is recommended.

How Suregraft 0.25 Tablet works:

Suregraft 0.25 mg tablets modulate the body's immune response, thereby reducing the risk of organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Suregraft 0.25 Tablet is of uncertain safety. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Suregraft 0.25 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Suregraft 0.25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Suregraft 0.25 Tablets may induce side effects that impair driving ability. Fatigue, a frequent side effect of Suregraft 0.25 Tablets, can also negatively impact driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Suregraft 0.25 Tablet without any required dosage modification.

LiverLiverCAUTION

Patients with liver impairment should use Suregraft 0.25 Tablet cautiously, potentially requiring dosage modification under medical supervision. Suregraft 0.25 Tablet is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Suregraft 0.25 Tablet :

NA

Facts to Know About Suregraft 0.25 Tablet

LabelValue
Chemical Type Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Suregraft 0.25 Tablet

Close monitoring is necessary during Suregraft 0.25 Tablet treatment. Your doctor will order blood tests to track red blood cell, white blood cell, and platelet counts, which may fall. Kidney and liver function, blood glucose, and cholesterol levels will also be monitored via blood tests.
Avoid grapefruit or grapefruit juice while using Suregraft 0.25 Tablets, as this combination can dangerously raise blood levels of the medication. Also avoid live vaccines and contact with recently vaccinated individuals.
Suregraft 0.25 tablets may cause serious side effects, including life-threatening allergic reactions (like angioedema) and kidney failure. Respiratory problems and infections are also possible.
Suregraft 0.25 Tablet is a kinase inhibitor used in cancer treatment. It works by limiting blood flow to tumors, thus hindering cancer cell growth and metastasis.
Take Suregraft 0.25 Tablet once or twice daily, consistently either with or without food. Always swallow the tablet whole with water; do not crush or chew.
Treatment duration for Suregraft 0.25 Tablet varies; it continues until clinical improvement is observed or intolerable side effects develop.
Regular brain scans, as directed by your doctor and treatment plan, are necessary to monitor the effectiveness of Suregraft 0.25 Tablet in reducing tumor size.
Suregraft 0.25 Tablets exhibit cytotoxicity against human cancer cells from breast, stomach, prostate, and kidney (renal cell carcinoma) tissues.
Suregraft 0.25 Tablet
538